Neurogene (NGNE) - Insiderhandel

Neurogene

NGNE

Datum	Typ	Insider	Position	Ø-Preis	Volumen
7.7.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	36,1 $	151.763 $
6.7.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	36,0 $	21.613 $
2.7.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	34,9 $	141.416 $
1.7.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	34,1 $	25.170 $
6.5.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	31,2 $	300.043 $
26.3.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	21,6 $	55.316 $
26.3.2026	Verkauf	Mcminn, Rachel	Chief Executive Officer	22,1 $	73.995 $
26.3.2026	Verkauf	Jordan, Julie	Chief Medical Officer	21,9 $	18.128 $
13.3.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	21,2 $	84.176 $
13.3.2026	Verkauf	Cobb, Stuart	Chief Scientific Officer	21,3 $	141.446 $
27.2.2026	Verkauf	Cvijic, Christine Mikail	President and CFO	25,1 $	120.526 $
14.5.2025	Verkauf	Cobb, Stuart	Chief Scientific Officer	15,2 $	103.003 $
13.3.2025	Verkauf	Cvijic, Christine Mikail	President and CFO	16,9 $	76.247 $
26.11.2024	Kauf	Samsara Biocapital Gp, LLC	Zehn-Prozent-Eigentümer	26,3 $	1.259.623 $
22.11.2024	Kauf	Mcminn, Rachel	Chief Executive Officer	20,4 $	969.000 $
22.11.2024	Kauf	Cvijic, Christine Mikail	President and CFO	20,5 $	491.400 $